With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
NPR

Up First

July 10, 2026 • Fighting between the U.S. and Iran appears to have paused after two days of clashing amid a shaky ceasefire. And, a look at what life is like inside Israel's expanding zone of control ...